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It is well-known that prostaglandins (PG) play a role in the regulation of 
numerous physiological processes (4, 9). P G deficit after their synthesis inhibi­
tion by indomethacin (IM) often leads to functional disorders (12). 
The influence of P G inhibition upon the activity of erythrocyte glucose-6-
phosphate dehydrogenase (G-6-PD) and catalase presents a definite interest, 
indeed. It is known that both enzymes play an important role in the maintenance 
of erythrocyte integrity by ensuring the stability of restored glutathione and by 
preventing hemoglobin oxidation (2, 14), therefore, they are directly related to 
erythrocyte homeostasis maintenance. 
A lot of hormonal, nutritional and other factors modulate G-6-PD activity 
(7, 13). 
Proceeding from the data about the influence of some PGs on deformation 
ability of erythrocyte membrane, fragility and swelling of erythrocyte and on 
hemolysis (5) as well as about Щ inhibitory effects on some enzymes (15) we set 
us the task of investigating the activity of erythrocyte G-6-PD and catalase af­
ter IM treatment; still more, in previous studies we have established erythrocyte 
count reduction and reticulocytosis (3). 
• 
Material and methods 
Our observation was made on 40 white female rats of Wistar breed with b. w. 
170—180 g. After assessing of the initial rates of erythrocytes and both enzymes 
the animals were divided into a control and experimental groups. Experimental 
animals were intraperitoneal^ administered IM injections twice daily of 3 mg/kg 
b. w. for 3 days while control ones — only solvent at the same volume (twin-f-al-
cohol diluted with saline). At the end of the experiment — on the 4 t h day — the 
erythrocytes and enzyme activity of G-6-PD and catalase were determined, too. 
G-6-PD activity was assessed by using of test-reagents from the firm Bohringer 
(GFR) and catalase one — after the method of Bach and Zubkova (cited after 1). 
G-6-PD activity was expressed in mE.109/erythrocytes but catalase one by means 
of the so-called catalase index (1). The data were processed by the methods of 
variation statistics. 
. . 
Results and discussion 
The data presented on table 1 demonstrate that ihree-day treatment with 
IM increases statistically significantly erythrocyte G-6-PD by 17.48 per cent 
(p<0.05) in comparison with initial rates while enzyme activity decreases by 
19.44 per cent in control rats (p<0.05). Erythrocyte count decreases signifi­
cantly (by 34.78 per cent — p<0.001) at the end of the trial in experimental 
animals while erythrocytes rt^e in number by 2.56 per cent in control ones. There 
are insignificant changes 6i catalase index. 
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T a b l e 1 
Erythrocyte catalase and G-6-PD after indomethacin treatment (dosis of 2 x 3 . 0 mg/kg)> 
v • End of the experiment 
Indexes n Initial levels 
n experimental 
% diffe-




act ivi ty 10 99.25^4.81 
(mE . 109 E r ) 
10 116.6it6.41 +17.48 10 83.09^:3.14 —19.44 
p<0.05 p<0.05 
Catalase index 8 0.966^:0.073 8 0.912:±0.049 —5.92 8 0.994^=0.061 +2.89 
p>0.05 p>0.05 
Erythrocytes 22 7.447=t0.264 20 5.525^0.240 —34.78 20 7.638^0.141 +2.56 
(x l O ^ / l ) * p<0.001 p>0.05 
Data are given as x and Sx . Percentage difference is calculated to ini t ia l values. 
• 
On the basis of our data we assume that P G deficit does not reflect on ery-
throcyte count by the way of G-6-PD and catalase commitment. St i l l more, ery-
throcyte G-6-PD is proved to be increased by 17.48 per cent (p<0.05) in compa-
rison to the initial levels and by 40,32 per cent as compared with the control ones 
at the end of the experiment. In our opinion, this can be due to the increased reti-
culocyte count. As far as it is known, enzyme reduces during erythrocyte ageing 
(10), still more, newly-formed erythrocyte even in individuals with enzyme de-
ficit possess practically normal erythrocyte G-6-PD activity. 
In previous investigations performed in our Department of Physiology a con-
siderable relative and absolute reticulocyte count increase after 3-day long treat-
ment with IM has been established (3). In our opinion, erythrocyte population 
rejuvenation can be one of the reasons for higher erythrocyte G-6-PD activity 
of IM treated animals. However, G-6-PD activity reduction in control rats re-
lains unclear yet. 
The lack of significant changes of the catalase index after IM treatment ex-
cludes almost completely the influence upon catalase in the case of P G deficit. 
It is possible that in this respect a role is played by the proved fact that IM reacts 
with molecular oxygen (6) and thus prevents cell membrane destruction. By this 
way, catalase system dispenses with functional realization and probably because 
of that it does not change essentially its activity. 
However, it is noteworthy that erythrocyte count decreases after IM treat-
ment. IM stabilizes erythrocyte membrane and can in high concentrations cause 
hemolysis and thus induce a biphasic effect — erythrocyte stability followed 
by lysis (11). 
Reduced erythrocyte number allows us to assume that at that IM dosis pro-
bably certain hemolytic changes occur that can stimulate erythropoiesis. 
It is possble that P G deficit influences upon ineffective erythropoiesis and 
the augmentation of the latter can be an additional reason for the lower erythro-
cyte count. This presumption is based on the facts that PGs not only increase-
erythropoietin biogenesis but also stimulate directly erythroid cell development 
and maturation (8). Probably, P G lack could disturb these processes. However,, 
additional investigations are required to prove this assumption. 
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We can draw the following conclusions: с I & a T 
1. Three-day long IM treatment increases erythrocyte G-6-PD activity but 
•does not change catalase index. It also reduces erythrocyte number. 
2. P G deficit does not influence upon erythrocyte count by means of G-6-PD 
and catalase commitment. v 
" i ' • 
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ВЛИЯНИЕ ИНДОМЕТАЦИНА НА ЭРИТРОЦИТНУЮ Г-6-ФД И НА КАТАЛАЗУ 
У КРЫС 
Т. Ганчев, Е. Станчева, Н. Недкова ] ' 
Р Е З Ю М Е т|'. 
Исследовано влияние простогландиновой ингибиции индометацином (2 по 3 мг/кг в 
течение трех дней) на эритроцитную каталазу и Г-6-ФД. Значение обоих энзимов для под­
держания целости эритроцитов хорошо известна. Устанавливается статистически значимое 
увеличение Г-6-ФД в конце эксперимента по отношению к исходному уровню у животных, 
третированных индометацином; при этом каталазный индекс не изменяется существенно. 
ОДна из возможных причин более высокой Г-6-ФД в эритроцитах крыс, третированных 
индометацином, объясняется наблюдаемым здесь ретикулоцитозом. Известно, чть молодые 
эритроциты являются носителями большего количества Г-6-ФД. Можно предположить, 
что недостаток простогландинов не отражается на число эритроцитов таким способом, кото­
р ы й вовлекал бы в этот процесс Г-6-ФД и каталазу . 
